ATE207536T1 - Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6 - Google Patents

Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6

Info

Publication number
ATE207536T1
ATE207536T1 AT96907047T AT96907047T ATE207536T1 AT E207536 T1 ATE207536 T1 AT E207536T1 AT 96907047 T AT96907047 T AT 96907047T AT 96907047 T AT96907047 T AT 96907047T AT E207536 T1 ATE207536 T1 AT E207536T1
Authority
AT
Austria
Prior art keywords
amino acid
tumor
int
acid sequences
nucleotide sequences
Prior art date
Application number
AT96907047T
Other languages
German (de)
English (en)
Inventor
Antonio Marchetti
Fiamma Buttitta
Gilbert H Smith
Robert Callahan
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE207536T1 publication Critical patent/ATE207536T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96907047T 1995-02-09 1996-02-09 Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6 ATE207536T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38599895A 1995-02-09 1995-02-09
PCT/US1996/001884 WO1996024672A1 (fr) 1995-02-09 1996-02-09 NUCLEOTIDES ET SEQUENCES AMINOACIDES DEDUITES DU GENE TUMORAL Int6

Publications (1)

Publication Number Publication Date
ATE207536T1 true ATE207536T1 (de) 2001-11-15

Family

ID=23523739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96907047T ATE207536T1 (de) 1995-02-09 1996-02-09 Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6

Country Status (8)

Country Link
US (4) US6255105B1 (fr)
EP (1) EP0809698B1 (fr)
JP (1) JP3911017B2 (fr)
AT (1) ATE207536T1 (fr)
AU (1) AU720270B2 (fr)
CA (1) CA2212573A1 (fr)
DE (1) DE69616288T2 (fr)
WO (1) WO1996024672A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037680B2 (en) * 1993-09-21 2006-05-02 The United States Of America As Represented By The Secretary Of The Army Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
WO2003016574A1 (fr) * 2001-08-16 2003-02-27 Zhifeng Shao Analyse de profils d'expression genique utilisant l'hybridation sequentielle
KR20080044205A (ko) * 2005-05-16 2008-05-20 도쿄 메트로폴리탄 오거니제이션 포 메디칼 리서치 저산소 스트레스 응답에 관여하는 Int6 단백질, 및 그 용도
JP2010222289A (ja) * 2009-03-23 2010-10-07 Tokyoto Igaku Kenkyu Kiko 細胞死を予防するための医薬剤
US20170313988A1 (en) 2014-10-21 2017-11-02 Consiglio Nazionale Delle Ricerche Methods and agents for cellualr reprogramming

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists

Also Published As

Publication number Publication date
EP0809698B1 (fr) 2001-10-24
DE69616288D1 (de) 2001-11-29
WO1996024672A1 (fr) 1996-08-15
US6342392B1 (en) 2002-01-29
AU5023096A (en) 1996-08-27
US20030044419A1 (en) 2003-03-06
US6737251B2 (en) 2004-05-18
US7067635B2 (en) 2006-06-27
AU720270B2 (en) 2000-05-25
CA2212573A1 (fr) 1996-08-15
JPH11500004A (ja) 1999-01-06
US20040141918A1 (en) 2004-07-22
EP0809698A1 (fr) 1997-12-03
US6255105B1 (en) 2001-07-03
DE69616288T2 (de) 2002-07-11
JP3911017B2 (ja) 2007-05-09

Similar Documents

Publication Publication Date Title
TR200700740T2 (tr) Nogo genlerinin nükleotid ve protein dizileri ve bunlar bazında yöntemler
CY1106216T1 (el) 5´ ESTs ΓΙΑ ΜΗ ΙΣΤΟ-ΕΙΔΙΚΕΣ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ
ATE269402T1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
HUP0004611A2 (hu) APRIL, egy új növekedési hatású fehérje
CY1105398T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
DE69633664D1 (de) Genetische marker für brust und eierstockkrebs
HK1031097A1 (en) Processes for preparing nucleic acid constructs
PT910647E (pt) Variantes hiperactivas da dnase i humana
ATE323161T1 (de) 5' ests für sekretierte proteine die im gehirn expremiert werden
HUP0002038A2 (hu) Génszekvenálási eszközök és eljárások
PT1053313E (pt) Oligonucleotidos ''antisense'' optimizados complementares de sequencias de dna metiltransferase
CA2079454A1 (fr) Steroide-5.alpha. reductase
WO1998019167A3 (fr) Gene de classe i du complexe majeur d'histocompatibilite humain a stress cellulaire regule
ATE188257T1 (de) Benutzung von reagenzien abgeleitet vom menschlichen metastase unterdrückungs gen kai1 in diagnostischen und gen-terapeutischen verfahren
WO1999033998A3 (fr) Sequences d'adn regulatrices du gene de la sous-unite telomerase catalytique humaine et leur utilisation a des fins diagnostiques et therapeutiques
WO1998059040A3 (fr) Sous-unite de telomerase catalytique humaine et son utilisation therapeutique et diagnostique
EP1536006A4 (fr) Antigenes cancereux et leur utilisation
ATE285239T1 (de) Dna enthaltende impfstoffen
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
NZ504445A (en) Nucleic acid sequences of genes of the high mobility group proteins and their use in treating tumours, vascular disorders and as a contraceptive
ATE207536T1 (de) Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6
WO2000008157A3 (fr) Genes humains transporteurs d'anions atnov
MY101874A (en) Vaccine
WO1996040764A3 (fr) Nucleotide et sequences d'acides amines de la region 1 hypervariable du gene e2 du virus de l'hepatite c
WO1999066051A3 (fr) Kinases en rapport avec nek et avec bub1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties